Journal of Targeted Oncology Research

Frequency : Bi-Annual (Two issues per year)
Editorial & Review Timeline
3 - 6 Days Initial Quality Review
30 Days Peer Evaluation Summary
45 - 60 Days Complete Editorial Processing Time

Drug Development and Clinical Trials

Drug development research involves the discovery, evaluation, and clinical assessment of new therapeutic agents for cancer treatment. Clinical trials help determine the safety, efficacy, and optimal use of investigational therapies across different patient populations. The journal encourages studies related to oncology drug research, clinical evaluation, and therapeutic innovation.